SCHEMBL15025618

SCHEMBL15025618

Cc1cccc(-c2cn(CC(=O)N3CCc4nc(C)oc4C3)c(-c3ccccc3)n2)c1

nearest known ligand 0.68

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 19/20 0.68
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15025558 0.88 GRM5 (0.88) GRM5
SCHEMBL15025561 0.88 GRM5 (0.71) GRM5
SCHEMBL15025564 0.83 GRM5 (0.65) GRM5
SCHEMBL15025217 0.82 GRM5 (0.89) GRM5
SCHEMBL15025725 0.82 GRM5 (0.78) GRM5
SCHEMBL15025218 0.81 GRM5 (1.00) GRM5
SCHEMBL15025574 0.80 GRM5 (0.86) GRM5
SCHEMBL15025208 0.79 GRM5 (0.78) GRM5
SCHEMBL15025740 0.78 GRM5 (0.79) GRM5
SCHEMBL15001830 0.76 GRM5 (0.49) GRM5ALDH1A1MAPTHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796467-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-08-05 US disclosed
US-8796467-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-08-05 US disclosed
US-20130150347-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-13 US disclosed
US-20130150347-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150347-A1 NOVEL COMPOUNDS GRM5, GRM1, GRIK5 GRM5 1/4885ALDH1A1 3660/4885MAPT 271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.